neferine has been researched along with Hepatocellular Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JS; Jung, HA; Kim, CY; Kim, GD; Kim, HM; Kim, NH; Yadunandam, AK; Yoon, JS | 1 |
Cai, C; Deng, G; Guo, C; Han, Y; Ma, J; Qu, Y; Shen, H; Yin, L; Zeng, S; Zhang, Y | 1 |
Ai, XH; Dong, L; Liu, HQ; Liu, YP; Tang, XQ | 1 |
3 other study(ies) available for neferine and Hepatocellular Carcinoma
Article | Year |
---|---|
Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Endoplasmic Reticulum Stress; Hepatitis B virus; Humans; Liver; Liver Neoplasms; Nelumbo; Phytotherapy; Plant Extracts; Seeds; Signal Transduction | 2013 |
The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Humans; Liver Neoplasms; Mice; Organoplatinum Compounds; Oxaliplatin; Phenotype; Signal Transduction; Snail Family Transcription Factors; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2017 |
[Effect of neferine on adriamycin-resistance of thermotolerant hepatocarcinoma cell line HepG2/thermotolerance].
Topics: Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hyperthermia, Induced; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2007 |